Study Title: Measuring the Improvements Through the Use of the Dysis™ Colposcope and the Dysismap™ in Detecting Dysplasia of the Cervix (IMPROVE) (Identifier: NCT02185599)
Study Purpose: This study will observe and quantify shifts in colposcopy practice and outcome improvements in U.S. community-based cervical screening colposcopy examinations after the introduction of the Dysis™ Colposcope with Advanced Cervical Scan, and collect colposcopy data across multiple sites in two arms: a prospective arm with Dysis™ being used for the examination, and a retrospective arm with data retrieved from patient charts.
Principal Investigator: Lance Talmage, M.D.
Study Coordinator: Stephanie Smiddy, RN, CRC. For more information, please contact 419.383.6794
Study Title: M12-815: A Phase 3 Study to Evaluate the Efficacy and Safety of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women. (NCT02654054)
Study Purpose: This study seeks to evaluate the efficacy, safety and tolerability of elagolix alone and in combination with estradiol/norethindrone acetate for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
Principal Investigator: Ronica Neuhoff, M.D.
Study Coordinator: Stephanie Smiddy, RN for more information, please contact 419.383.6794